BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33848414)

  • 1. Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors.
    Kang D; Kim Y; Lim J; Yoon J; Kim S; Kang E; Nam H; Shim S; Lee M; Bok H; Lee SW; Shin SY; Ahn JS; Oh D; Cho J
    Cancer Res Treat; 2022 Jan; 54(1):10-19. PubMed ID: 33848414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases.
    Kang D; Lim J; Kim BG; Nam H; Kim Y; Kang E; Kim S; Shim S; Lee M; Yoon J; Lee H; Shin SH; Park HY; Cho J
    J Thorac Dis; 2021 Oct; 13(10):5752-5764. PubMed ID: 34795924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems.
    Kim Y; Kang D; Kang E; Lim J; Kim S; Nam H; Shim S; Lee M; Moon YW; Lim SJ; Sung KS; Cho J
    BMC Sports Sci Med Rehabil; 2021 Nov; 13(1):148. PubMed ID: 34819153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
    Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
    Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Validation of the Korean Version of the Cancer Survivors' Unmet Needs (CaSUN) Scale among Korean Non-Small Cell Lung Cancer Survivors.
    Kang D; Lee G; Kim S; Nam H; Kong S; Shim S; Lee JK; Jung W; Shin S; Kim HK; Zo JI; Shim YM; Shin DW; Cho J
    Cancer Res Treat; 2023 Jan; 55(1):61-72. PubMed ID: 35209702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the psychometric properties of the simplified Chinese version of PROMIS-29 version 2.1 in patients with hematologic malignancies.
    Zhang Q; Zhao J; Liu Y; Cui Y; Wang W; Li J; Liu Y; Tian F; Wang Z; Zhang H; Liu G; Wu Y; Li Q; Hu T; Zhang W; Xie W
    Sci Rep; 2024 May; 14(1):11153. PubMed ID: 38750224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evaluation of the Chinese version of the patient-reported outcomes measurement information system 29-item profile in patients with aortic dissection.
    Huang W; Wu Q; Zhang Y; Tian C; Huang H; Huang S; Zhou Y; He J; Wang H
    Health Qual Life Outcomes; 2022 Jun; 20(1):94. PubMed ID: 35701761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
    Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
    Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.
    Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K
    J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
    Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
    Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of PROMIS-29 domain scores among adult burn survivors: A National Institute on Disability, Independent Living, and Rehabilitation Research Burn Model System Study.
    McMullen K; Bamer A; Ryan CM; Schneider JC; Gibran N; Stewart BT; Mroz T; Wolf S; Amtmann D
    J Trauma Acute Care Surg; 2022 Jan; 92(1):213-222. PubMed ID: 34284470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands.
    van Balen EC; Haverman L; Hassan S; Taal EM; Smit C; Driessens MH; Beckers EAM; Coppens M; Eikenboom J; Hooimeijer HL; Leebeek FWG; van Vulpen LFD; Schols SEM; Terwee CB; Rosendaal FR; van der Bom JG; Gouw SC
    J Thromb Haemost; 2021 Nov; 19(11):2687-2701. PubMed ID: 34245088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese Version of Pediatric Patient-Reported Outcomes Measurement Information System Short Form Measures: Reliability, Validity, and Factorial Structure Assessment in Children With Cancer in China.
    Liu Y; Yuan C; Wang J; Shen N; Shen M; Hinds PS
    Cancer Nurs; 2019; 42(6):430-438. PubMed ID: 30124482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
    Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.